Don’t Miss the Conversation: The Future of Vaccines, Variants and Treatments, including Monoclonal Antibody Therapeutics


ASPR personal holding American flag standing next to Columbia officials holding Columbia Flag

ASPR’s Critical Role in U.S. Donations of COVID-19 Vaccines: A Look Behind the Scenes

More than 70% of adults in the United States have received at least one shot of COVID-19 vaccine, and BARDA has purchased enough doses of COVID-19 vaccines to cover everyone in the United States. At the same time, federal health officials recognize that the pandemic is a global struggle and the SARS-CoV-2 virus doesn’t stop at any of our national borders. To stop the spread of COVID-19 in the U.S. and decrease the chances of new, even more dangerous, variants emerging, we must help prevent the spread of the pandemic worldwide. That is why, with ASPR’s coordination, the U.S. is taking the global lead in supporting countries in need of the pandemic vaccine.

Read Blog
health care provider administering a vaccine
HHS Takes Action to Expand Access
to Seasonal Flu Vaccines,
Authorizing Qualified Pharmacy
Technicians/Interns as Vaccinators
Learn More
Kingman Regional Medical Center interviewer speaks with Dr. Michael Anderson
In Latest Interview, ASPR’s Michael
Anderson, MD, Explains Everything
You Need to Know about COVID-19
Monoclonal Antibody Therapy
Watch Interview
two healthcare providers in mask looking at camera
Don’t Miss the Conversation:
The Future of Vaccines, Variants and
Treatments, including Monoclonal
Antibody Therapeutics
Watch on Facebook
Healthcare provider checking on infusion bag
Real-world Effect of
Monoclonal Antibody Treatment in
COVID-19 Patients in a Diverse
Population in the United States
Read Article
scientist working in a lab
BARDA, NIAID, Fred Hutch Scientists
Lead Collaboration to Identify
“Correlates of Protection” that Could
Aid COVID-19 Vaccine Development
Read Article
NDMS team provides surge support at Our Lady of the Lakes Hospital in Baton Rouge, LA
National Disaster Medical System
Teams Deploy to Help with COVID-19
Surges in Louisiana, Arizona,
and Mississippi
Learn More
Cepheid's rapid diagnostic test
BARDA, Cepheid Team Up on Rapid
Diagnostic for Pooled Samples to
Address COVID-19, Detect Novel
and Emerging Coronaviruses
Read Announcement
U.S. Biologic's gummies
BARDA DRIVe Partners with
U.S. Biologic Inc. to Advance the
Development of an Oral Vaccine
for Pandemic Influenza
Read More
Wearable watch technology on a person's wrist
BARDA, NIH, Other Federal Agencies
Host Federal Wearables Summit on
August 31: Tune in to Learn about the
Future of Wearable Health Sensors
Register Today
Wake Forest's lung on a chip technology
What if You Could Replace a Clinical
Trial with a 2-Inch Chip? BARDA,
Wake Forest Institute for Regenerative
Medicine Partner on New Technology
Learn More